These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11039843)

  • 41. Treatment of telangiectasia macularis eruptiva perstans with montelukast.
    Cengizlier R; Hücümenoğlu S; Ozen A; Tülin Sayli R
    Allergol Immunopathol (Madr); 2009; 37(6):334-6. PubMed ID: 19913347
    [No Abstract]   [Full Text] [Related]  

  • 42. Persistent Facial Flushing in a Patient with Telangiectasia Macularis Eruptiva Perstans: An Unusual but Should Emphasized Clinical Finding.
    He X; Wang B; Jia X; Li Y; Yan H; Mu Q; Chen S
    Clin Cosmet Investig Dermatol; 2022; 15():1309-1312. PubMed ID: 35847419
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Telangiectasia macularis eruptiva perstans and multiple myeloma.
    Bachmeyer C; Guillemette J; Blum L; Turc Y; Dhôte R; Fermand JP; Aractingi S
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):972-4. PubMed ID: 11044837
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prolonged losses of consciousness disclosing mastocytosis of the telangiectasia macularis eruptiva perstans type].
    Bonnefoy M; Rouchouse B; Clavreul C; Decousus D; Claudy A
    Ann Dermatol Venereol; 1986; 113(3):259-62. PubMed ID: 3752866
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of telangiectasia macularis eruptiva perstans with the 585-nm flashlamp-pumped dye laser.
    Ellis DL
    Dermatol Surg; 1996 Jan; 22(1):33-7. PubMed ID: 8556255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unilateral facial telangiectasia macularis eruptiva perstans.
    Fried SZ; Lynfield YL
    J Am Acad Dermatol; 1987 Jan; 16(1 Pt 2):250-2. PubMed ID: 3819061
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mastocytosis and the skin.
    Soter NA
    Hematol Oncol Clin North Am; 2000 Jun; 14(3):537-55, vi. PubMed ID: 10909039
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Telangiectasia macularis eruptiva perstans.
    Altiner A; Tzu J; Patel R; Meehan S; Sanchez M
    Dermatol Online J; 2011 Oct; 17(10):7. PubMed ID: 22031633
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cutaneous mastocytosis in a patient with primary Sjögren's syndrome.
    Kalay Erbay S; Stewart C; Hassanein A; Fletcher A; Bhattacharyya I; Cohen D; Wesson SK; Weinstein J; Lyons R; Reeves WH
    J Rheumatol; 2006 Aug; 33(8):1697-700. PubMed ID: 16881127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Erythrodermic mastocytosis.
    Requena L
    Cutis; 1992 Mar; 49(3):189-92. PubMed ID: 1533360
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful treatment of psoriasis with risankizumab in a patient with telangiectasia macularis eruptiva perstans.
    Barber C; Song EJ
    JAAD Case Rep; 2022 Jun; 24():71-73. PubMed ID: 35647249
    [No Abstract]   [Full Text] [Related]  

  • 52. Unilateral telangiectasia macularis eruptiva perstans with an unusual clinical presentation.
    Jia QN; Fang K; Qu T
    J Dermatol; 2018 Jul; 45(7):e201-e202. PubMed ID: 29424045
    [No Abstract]   [Full Text] [Related]  

  • 53. Cutaneous mastocytosis: a review focusing on the pediatric population.
    Briley LD; Phillips CM
    Clin Pediatr (Phila); 2008 Oct; 47(8):757-61. PubMed ID: 18502981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Telangiectasia Macularis Eruptiva Perstans Revisited.
    Heymann WR
    Skinmed; 2017; 15(4):287-288. PubMed ID: 28859740
    [No Abstract]   [Full Text] [Related]  

  • 55. Cutaneous mastocytosis as a rare differential diagnosis for unilateral chronic facial pain and erythema: a case report.
    Troeltzsch M; Berndt R; Woodlock T; Messlinger K; Troeltzsch M
    J Orofac Pain; 2013; 27(4):367-71. PubMed ID: 24171187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unilateral facial telangiectasia macularis eruptiva perstans.
    Gonzalez-Castro U; Luelmo-Aguilar J; Castells-Rodellas A
    Int J Dermatol; 1993 Feb; 32(2):123-4. PubMed ID: 8440554
    [No Abstract]   [Full Text] [Related]  

  • 57. Newly Developed Psoriasis in a Patient with Telangiectasia Macularis Eruptiva Perstans and Systemic Mastocytosis Treated with Interferon.
    Péčová T; Burjanivová T; Malicherová B; Péč MJ; Rohoň I; Madleňák M; Adamicová K; Péč J
    Case Rep Dermatol; 2021; 13(3):558-562. PubMed ID: 35082619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Child case of linear variant of telangiectasia macularis eruptiva perstans.
    Tsutsui Y; Koga M; Koga K; Imafuku S
    J Dermatol; 2019 Dec; 46(12):e469-e470. PubMed ID: 31531875
    [No Abstract]   [Full Text] [Related]  

  • 59. [Cutaneous collagenous vasculopathy: a rare cause of generalized telangiectasia].
    Bernard S; Cawet B; Theate Y; Bataille AC; Marot L
    Ann Dermatol Venereol; 2012 May; 139(5):381-6. PubMed ID: 22578343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A case of omalizumab as a successful treatment for telangiectasia macularis eruptiva perstans.
    Mortimore AM; Barsoum R; Lambie D; McMeniman E
    Australas J Dermatol; 2022 Feb; 63(1):102-104. PubMed ID: 34314029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.